International Transporter Consortium Workshop Two (ITCW2)

Membrane Transporters in Drug Development: Best Practices and Future Direction Scientists from all sectors of drug discovery, development and regulatory review will attend the second International Transporter Consortium (ITC) workshop co-sponsored by ASCPT. Date: March 12-13, 2012 Location: Gaylord National Hotel and Convention Center, National Harbor, Maryland. Learn more about the hotel and location. Click here to view the ITCW2 Pre-Conference Final Program View the General Information page of the Program for onsite registration hours and additional information about ITCW2.

Members of the International Transporter Consortium. (*Cochairs), Clinical Pharmacology & Therapeutics (2010) 87 1, 32–36

About the ITC

The International Transporter Consortium (ITC) is organizing a second workshop (ITCW2; March 12 and 13, 2012) cosponsored by ASCPT which will precede the ASCPT Annual Meeting (see link below). The goals of will be focused on the current status of transporters with emphasis on the role of multiple transporters in Pharmaceutical Research and Development with a specific focus on potential clinical impact.  As with the first workshop, and captured in the subsequent white paper (Nature Reviews Drug Discovery 9, p215 (2010), the perspectives of Academia, Industry and Regulators will be presented.  Expanding on the original white paper, and in response to requests from the scientific community, ITCW2 will include more contributions from Europe and Asia.  Sessions will include updates on current status, consideration of additional transporters such as MRP, OST, MATE and BSEP, tools and techniques, as well as experiences related to responses to the first white paper from industry and regulators (FDA, EMA and PMDA).